logo
State of the Journal: 2010
Acknowledgment of Reviewers
RBM5 as a Putative Tumor Suppressor Gene for Lung Cancer
IL1B rs1143634 Polymorphism, Cigarette Smoking, Alcohol Use, and Lung Cancer Risk in a Japanese Population
High MET Gene Copy Number Leads to Shorter Survival in Patients with Non-small Cell Lung Cancer
Overexpression of the Mammalian Target of Rapamycin
Expression of Class III Beta-Tubulin Correlates with Unfavorable Survival Outcome in Patients with Resected Non-small Cell Lung Cancer
A Pessimistic Explanatory Style Is Prognostic for Poor Lung Cancer Survival
Histological Scoring for Small Lung Adenocarcinomas 2 cm or Less in Diameter
Impact of the New Lung Cancer Staging System for a Predominantly Advanced-Disease Patient Population
Are There Imaging Characteristics Associated with Epidermal Growth Factor Receptor and KRAS Mutations in Patients with Adenocarcinoma of the Lung with Bronchioloalveolar Features?
Can a Thoracic Surgeon Identify Lymph Node Metastases during Surgery Based on Their Size?
Safety and Efficacy of Combining Sunitinib with Bevacizumab + Paclitaxel/Carboplatin in Non-small Cell Lung Cancer
First-Line Gefitinib Treatment for Patients with Advanced Non-small Cell Lung Cancer with Poor Performance Status
Phase II, Double-Blinded, Randomized Study of Enzastaurin Plus Pemetrexed as Second-Line Therapy in Patients with Advanced Non-small Cell Lung Cancer
Second-Line Therapy for Elderly Patients with Non-small Cell Lung Cancer Who Failed Previous Chemotherapy Is as Effective as for Younger Patients
A Phase II Study of Dasatinib in Patients with Chemosensitive Relapsed Small Cell Lung Cancer (Cancer and Leukemia Group B 30602)
Role of Integrated 18-Fluorodeoxyglucose Position Emission Tomography-Computed Tomography in Patients Surveillance after Multimodality Therapy of Malignant Pleural Mesothelioma
A Systematic Review of Restaging After Induction Therapy for Stage IIIa Lung Cancer
De Novo Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in EGFR Mutation-Positive Patients with Non-small Cell Lung Cancer
A Case of Pemetrexed-Induced Acute Lung Injury in Non-small Cell Lung Cancer
Primary Non-Hodgkin's Lymphoma of the Trachea
A Pathological Complete Response in Malignant Pleural Mesothelioma after Combination Chemotherapy with Carboplatin and Pemetrexed
Osteoblastic Response in Patients with Non-small Cell Lung Cancer with Activating EGFR Mutations and Bone Metastases during Treatment with EGFR Kinase Inhibitors
The Role of EBUS-TBNA for the Assessment of Hilar Lymph Nodes